Nasal Antisepsis for C. Auris Prevention
Recruiting
Phase 4
Interventional Study
Candida Auris Infection
Colonization, Asymptomatic
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 120 (estimated)
- Sponsor
- Mary K Hayden · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a randomized, controlled, open-label trial of effect of 10% povidone iodine intranasal antisepsis on the detection of Candida auris.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* History of C. auris colonization or infection
* Patient in a participating facility
Exclusion Criteria:
* History of severe allergy to iodine-based products, defined as anaphylaxis or rash
* Currently breastfeeding or pregnant
* Non-English language speaking
Contacts